Challenge of Chorioptes infestation

Infestation with the mite Chorioptes bovis can prove difficult to eradicate. A Swiss study found that two doses of moxidectin oral paste, combined with environmental treatment, failed to eliminate the parasite from heavily feathered draft horses.

The study, led by Silvia Rüfenacht of the Dermatology Unit of the Department of Clinical Veterinary Medicine at the University of Berne, was reported recently in Veterinary Dermatology.

Chorioptes bovis is a particular problem of draft-type horses with hairy legs. The mites live on the skin surface, feeding on skin scales, but may survive for three weeks or more in the environment. They tend to be more of a problem in the winter when horses spend more time housed.

Not only do the mites cause irritation, they may contribute to the development of chronic pastern dermatitis - thickened swollen skin with warty ("verrucose") lumps.

The study was designed to use licenced products and be practical for owners to carry out.

Horses were treated twice, three weeks apart, with 0.4mg/kg moxidectin oral paste. Environmental treatment, carried out on days 0 and 14, consisted of removing all bedding, brushing out the stable, grooming area, and horse transporter. All surfaces, tack, and grooming equipment were treated with anti-parasitic disinfectants.

Horses were examined just before the first treatment (day 0) and 14 days, 6 weeks and 6 months later. The clinician, who did not know which horses were in the treatment  or placebo group, took skin scrapings and assessed the degree amount extent of crusting and skin folds

Initially, all horses showed pruritus (itching) manifest as rubbing, biting or stamping, and this continued throughout the study. Treatment had no significant effect on the number of mites found in skin scrapings, nor on the severity of skin folds.

The only significant finding was that the treated horses showed a decrease in skin crusting over the 6 month follow up period. But that was the only difference between the treatment and placebo groups. There was no other difference in clinical signs or in the number of mites found between the two groups.